all glp 1 drugs Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 receptor agonists | How
Description
Many people find pills difficult to swallow
Interestingly, while tirzepatide acts as an agonist of the GLP-1 receptor, it may effectively act as a GIP receptor antagonist
Until the data of the SURPASS-CVOT trial are available, tirzepatide will most likely have a place in the algorithm of T2D therapy for patients with obesity and T2D that have the therapeutic aim to normalize glycemia and decrease body weight
Documentation of current height and body weight to calculate BMI
L., Li, Y., & Lu, H
[DOI] [PubMed] 94.Wang L, et al
